Covestor
AMRX icon

Covestor’s Amneal Pharmaceuticals AMRX Stock Holding History

Covestor’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$63K Sell
3,150
-841
-21% -$15.2K 0.04% 620
2026
Q2 		$69K Buy
3,991
+793
+25% +$10.9K 0.04% 592
2026
Q1 		$40K Sell
3,198
-6,420
-67% -$86.2K 0.03% 822
2025
Q4 		$121K Buy
9,618
+9,425
+4,883% +$108K 0.06% 464
2025
Q3 		$2K Buy
193
+84
+77% +$754 ﹤0.01% 1911
2025
Q2 		$1K Buy
109
+20
+22% +$151 ﹤0.01% 1923
2025
Q1 		$1K Buy
89
+27
+44% +$225 ﹤0.01% 1911
2024
Q4 		$0 Sell
62
-16
-21% -$134 ﹤0.01% 2191
2024
Q3 		$1K Buy
78
+57
+271% +$446 ﹤0.01% 1882
2024
Q2 		$0 Hold
21
– – ﹤0.01% 2202
2024
Q1 		$0 Sell
21
-2
-9% -$11 ﹤0.01% 2198
2023
Q4 		$0 Sell
23
-14
-38% -$62 ﹤0.01% 2102
2023
Q3 		$0 Sell
37
-5
-12% -$19 ﹤0.01% 2071
2023
Q2 		$0 Sell
42
-1,770
-98% -$3.77K ﹤0.01% 2091
2023
Q1 		$3K Buy
1,812
+349
+24% +$695 ﹤0.01% 1650
2022
Q4 		$3K Sell
1,463
-195
-12% -$437 ﹤0.01% 1667
2022
Q3 		$3K Buy
1,658
+1,604
+2,970% +$4.5K ﹤0.01% 1596
2022
Q2 		$0 Sell
54
-40
-43% -$145 ﹤0.01% 1865
2022
Q1 		$0 Sell
94
-6,525
-99% -$28.9K ﹤0.01% 2066
2021
Q4 		$32K Buy
+6,619
New +$33K 0.04% 729

Other funds holding AMRX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

Covestor's AMRX Position: Q3 2026 in Review

Covestor reduced its Amneal Pharmaceuticals (AMRX) stake by 21% in Q3 2026, selling an estimated $15.2K and leaving 3,150 shares worth $63K. The position accounts for 0.04% of the portfolio, ranked #620.

Covestor first reported a position in AMRX in Q4 2021 and has held it in 20 quarters since. The position peaked at $121K in Q4 2025. 264 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Covestor held 3,150 shares of Amneal Pharmaceuticals worth $63K as of Q3 2026.
  • Covestor sold 841 Amneal Pharmaceuticals shares in Q3 2026, an estimated $15.2K.
  • Amneal Pharmaceuticals made up 0.04% of Covestor's portfolio in Q3 2026, its #620 holding.
  • Covestor first reported a position in Amneal Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Amneal Pharmaceuticals position peaked at $121K in Q4 2025.
  • 264 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.